Nerve blocks used for regional anesthesia in knee surgery can be made safer using ultrasound guidance for needle placement, lowering the necessary dose, according to a recent Italian study.
Nerve blocks used for regional anesthesia in knee surgery can be made safer using ultrasound guidance for needle placement, lowering the necessary dose, according to a recent Italian study.
Injecting anesthesia in the wrong place can cause local nerve damage, and even clinically acceptable doses of regional anesthetics have been reported to cause sudden acute cardiovascular toxicity and central nervous system toxicity to the point of coma and death. These risks are lessened as anesthesia volume drops.
Dr. Andrea Casati and colleagues in the anesthesia and pain therapy department at the University of Parma wondered if using ultrasound guidance to place the needle more precisely could allow them to use smaller doses of anesthetic.
Sixty patients undergoing arthroscopic knee surgery were given standard premedication and a sciatic nerve block. All subjects were given femoral nerve blocks using ropivacaine 0.5%. Thirty patients were injected using standard nerve stimulation for needle placement; needle placement for the other 30 patients was guided with ultrasound.
Researchers used 12 mL of anesthetic on the first patient in each group. Half an hour after injection, a blinded observer checked for sensation in the femoral nerve. If the patient felt a pinprick in two places, researchers increased the dose for the next patient by 3 mL. If there was no sensation half an hour after injection, the researchers decreased the next patient's dose by 3 mL. In this way they could fine-tune the range of effective anesthetic volume.
When results were examined, investigators found that the mean effective dose for the patients who had ultrasound guidance was 15 mL. The mean effective dose for those in the nerve stimulation group was 26 mL. Further statistical analysis supported these results. The researchers concluded that ultrasound guidance allowed them to reduce the volume of anesthetic by 42% compared with using nerve stimulation guidance.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Month, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.